The Premature Senescence in Breast Cancer Treatment Strategy
Cellular senescence is a permanent blockade of cell proliferation. In response to therapy-induced stress, cancer cells undergo apoptosis or premature senescence. In apoptosis-resistant cancer cells or at lower doses of anticancer drugs, therapy-induced stress leads to premature senescence. The role...
Main Author: | Małgorzata Milczarek |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-07-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/12/7/1815 |
Similar Items
-
The Contribution of Physiological and Accelerated Aging to Cancer Progression Through Senescence-Induced Inflammation
by: Jorge Morales-Valencia, et al.
Published: (2021-09-01) -
The Jekyll and Hyde of Cellular Senescence in Cancer
by: Dilara Demirci, et al.
Published: (2021-01-01) -
Senescence in the Development and Response to Cancer with Immunotherapy: A Double-Edged Sword
by: Anthony M. Battram, et al.
Published: (2020-06-01) -
Stress‐induced premature senescence activated by the SENEX gene mediates apoptosis resistance of diffuse large B‐cell lymphoma via promoting immunosuppressive cells and cytokines
by: Jiyu Wang, et al.
Published: (2020-12-01) -
The redox-senescence axis and its therapeutic targeting
by: Natalie YL. Ngoi, et al.
Published: (2021-09-01)